{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:27:40Z","timestamp":1750134460272,"version":"3.37.3"},"reference-count":83,"publisher":"IOP Publishing","issue":"2","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"crossref","award":["2209-B Industry Oriented Research Project Support"],"award-info":[{"award-number":["2209-B Industry Oriented Research Project Support"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Nanotechnology"],"published-print":{"date-parts":[[2025,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Nanoparticle-based antigen carrier systems have become a significant area of research with the advancement of nanotechnology. Biodegradable polymers have emerged as particularly promising carrier vehicles due to their ability to address the limitations of existing vaccine systems. In this study, we successfully encapsulated the G5-24 linear peptide, located between amino acids 253 and 275 in the primary sequence of the rabies virus G protein, into biodegradable and biocompatible PLGA copolymer using the double emulsion solvent evaporation method. The resulting nanoparticles had a size of approximately 230.9 \u00b1 0.9074 nm, with a PDI value of 0.168 \u00b1 0.017 and a zeta potential value of \u22129.86 \u00b1 0.132 mV. SEM images confirmed that the synthesized nanoparticles were uniform in size and distribution. Additionally, FTIR spectra indicated successful peptide loading into the nanoparticles. The encapsulation efficiency of the peptide-loaded nanoparticles was 73.3%, with a peptide loading capacity of 48.2% and a reaction yield of 30.4%. Peptide release studies demonstrated that 65.55% of the peptide was released in a controlled manner over 28 d, following a \u2018biphasic burst release\u2019 profile consistent with the degradation profile of PLGA. This controlled release is particularly beneficial for vaccine studies. Cytotoxicity tests revealed that the R-NP formulation did not induce cytotoxicity in fibroblast cells and enhanced NO production in macrophages, indicating its potential for vaccine development.<\/jats:p>","DOI":"10.1088\/1361-6528\/ad84fe","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T22:48:06Z","timestamp":1728514086000},"page":"025603","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity"],"prefix":"10.1088","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-1559","authenticated-orcid":true,"given":"K\u00fcbra","family":"Bezir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7176-4484","authenticated-orcid":true,"given":"Pelin","family":"Pelit Arayici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bu\u015fra","family":"Akg\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emrah \u015eefik","family":"Abamor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-6642","authenticated-orcid":true,"given":"Serap","family":"Acar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"nanoad84febib1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-12-818731-9.00051-3","author":"Ogino","year":"2022"},{"key":"nanoad84febib2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2018.12.009","article-title":"Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses","volume":"35","author":"Du Pont","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"nanoad84febib3","first-page":"103","author":"Wallace","year":"2019","edition":"4th edn,"},{"key":"nanoad84febib4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"nanoad84febib5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.786953","article-title":"Lyssaviruses and the fatal encephalitic disease rabies","volume":"12","author":"Scott","year":"2021","journal-title":"Front. Immunol."},{"key":"nanoad84febib6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"Hemachudha","year":"2013","journal-title":"Lancet Neurol."},{"key":"nanoad84febib7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"key":"nanoad84febib8","first-page":"193","article-title":"A new approach for development of synthetic peptide vaccines for viral vaccines","volume":"7","author":"Pelit Arayici","year":"2016","journal-title":"Sigma. J. Eng. Nat. Sci."},{"key":"nanoad84febib9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2022.05.001","article-title":"Role of the glycoprotein thorns in anxious effects of rabies virus: evidence from an animal study","volume":"185","author":"Ghassemi","year":"2022","journal-title":"Brain Res. Bull."},{"key":"nanoad84febib10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-virology-100114-055157","article-title":"Everything you always wanted to know about rabies virus (but were afraid to ask)","volume":"2","author":"Davis","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"nanoad84febib11","first-page":"43","author":"William","year":"2020","edition":"4th edn,"},{"key":"nanoad84febib12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2019.105567","article-title":"Novel strategy for expression and characterization of rabies virus glycoprotein","volume":"168","author":"Zhao","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"nanoad84febib13","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1016\/j.vaccine.2009.05.055","article-title":"Peptide mimotopes of rabies virus glycoprotein with immunogenic activity","volume":"27","author":"Houimel","year":"2009","journal-title":"Vaccine"},{"key":"nanoad84febib14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00705-016-3128-9","article-title":"Rabies vaccine development by expression of recombinant viral glycoprotein","volume":"162","author":"Astray","year":"2017","journal-title":"Arch. Virol."},{"key":"nanoad84febib15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.vetmic.2012.11.031","article-title":"Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms","volume":"162","author":"Zhang","year":"2013","journal-title":"Vet. Microbiol."},{"key":"nanoad84febib16","first-page":"477","article-title":"Development of an edible rabies vaccine in maize using the Vnukovo strain","volume":"131","author":"LozaRubio","year":"2008","journal-title":"Dev. Biol."},{"key":"nanoad84febib17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","volume":"74","author":"van der Heijden","year":"1993","journal-title":"J. Gen. Virol."},{"key":"nanoad84febib18","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","article-title":"Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine","volume":"64","author":"Dietzschold","year":"1990","journal-title":"Virol. J."},{"key":"nanoad84febib19","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1016\/j.vaccine.2008.10.020","article-title":"A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals","volume":"26","author":"Niederh\u00e4user","year":"2008","journal-title":"Vaccine"},{"key":"nanoad84febib20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actbio.2021.05.003","article-title":"Peptide-based supramolecular vaccine systems","volume":"133","author":"O\u2019Neill","year":"2021","journal-title":"Acta Biomater."},{"key":"nanoad84febib21","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2019","journal-title":"Chem. Rev."},{"key":"nanoad84febib22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/181646","article-title":"An overview on the field of micro-and nanotechnologies for synthetic peptide-based vaccines","volume":"2011","author":"Salvador","year":"2011","journal-title":"J. Drug Deliv."},{"key":"nanoad84febib23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1134\/S1990750810040025","article-title":"Synthetic peptide vaccines","volume":"4","author":"Moisa","year":"2010","journal-title":"Biochem. Suppl. B"},{"key":"nanoad84febib24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.03.001","article-title":"Peptide immunotherapy in vaccine development: from epitope to adjuvant","volume":"99","author":"Yang","year":"2015","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"nanoad84febib25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0264-410X(02)00732-6","article-title":"Synthetic IgE peptide vaccine for immunotherapy of allergy","volume":"21","author":"Wang","year":"2003","journal-title":"Vaccine"},{"key":"nanoad84febib26","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1016\/j.vaccine.2006.03.009","article-title":"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects","volume":"24","author":"Firbas","year":"2006","journal-title":"Vaccine"},{"key":"nanoad84febib27","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.2174\/092986709789909648","article-title":"Peptide-based anticancer vaccines: recent advances and future perspectives","volume":"16","author":"Mocellin","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"nanoad84febib28","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","article-title":"The second-generation active A\u03b2 immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects","volume":"31","author":"Wiessner","year":"2011","journal-title":"J. Neurosci."},{"key":"nanoad84febib29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"nanoad84febib30","doi-asserted-by":"publisher","first-page":"14184","DOI":"10.1021\/acs.jmedchem.0c00848","article-title":"Medicinal chemistry and methodological advances in the development of peptide-based vaccines: miniperspective","volume":"63","author":"Sabatino","year":"2020","journal-title":"J. Med. Chem."},{"key":"nanoad84febib31","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11095-023-03540-x","article-title":"Validation of multi-epitope peptides encapsulated in PLGA nanoparticles against influenza A virus","volume":"40","author":"Heng","year":"2023","journal-title":"Pharm. Res."},{"key":"nanoad84febib32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"key":"nanoad84febib33","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"12","author":"Allahyari","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"nanoad84febib34","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccin. Immunother"},{"key":"nanoad84febib35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.nano.2010.03.001","article-title":"Delivery of a peptide via poly (d, l-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell\u2013stimulatory capacity","volume":"6","author":"Clawson","year":"2010","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"nanoad84febib36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10989-018-9739-0","article-title":"Synthesis, characterization and lipophilicity study of Brucella abortus\u2019 immunogenic peptide sequence that can be used in the future vaccination studies","volume":"25","author":"Acar","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"nanoad84febib37","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1002\/slct.201901375","article-title":"Rabies virus 31D peptide\u2010[P (VP\u2010co\u2010AA)] conjugates: synthesis, characterization and cytotoxicity evaluation","volume":"4","author":"Arayici","year":"2019","journal-title":"ChemistrySelect"},{"key":"nanoad84febib38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-015-0195-2","article-title":"Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles","volume":"22","author":"Derman","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"nanoad84febib39","first-page":"93","article-title":"Rutin Y\u00fckl\u00fc Kitosan Nanopartik\u00fcllerinin Sentezi, Karakterizasyonu ve Antioksidan Aktivitesinin De\u011ferlendirilmesi","volume":"3","author":"Beyo\u011flu","year":"2020","journal-title":"Eurasian J. Bio. Chem. Sci."},{"key":"nanoad84febib40","doi-asserted-by":"publisher","DOI":"10.1088\/2053-1591\/ad5e61","article-title":"Enhanced antimicrobial potency and stability of juglone\/\u03b2-cyclodextrin inclusion complexes: a comparative study of formulation methods","volume":"11","author":"Pelit Arayici","year":"2024","journal-title":"Mater. Res. Express"},{"key":"nanoad84febib41","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.biomaterials.2013.11.073","article-title":"Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"nanoad84febib42","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113421","article-title":"Effect of polycation coating on the long-term pulsatile release of antigenic ESAT-61\u201320 peptide from PLGA nanoparticles","volume":"228","author":"B\u00fcy\u00fckbayraktar","year":"2023","journal-title":"Colloids Surf. B"},{"key":"nanoad84febib43","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ac1c22","article-title":"A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2","volume":"32","author":"Ucar","year":"2021","journal-title":"Nanotechnology"},{"key":"nanoad84febib44","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.630","article-title":"Synthesis of chitosan nanoparticles for controlled release of amiodarone","volume":"82","author":"Buyuk","year":"2020","journal-title":"Indian J. Pharm. Sci."},{"key":"nanoad84febib45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/21691401.2018.1556213","article-title":"Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells","volume":"47","author":"Ersoz","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"nanoad84febib46","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ad1444","article-title":"Ketoconazole-loading strategy to improve antifungal activity and overcome cytotoxicity on human renal proximal tubular epithelial cells","volume":"35","author":"Coksu","year":"2023","journal-title":"Nanotechnology"},{"key":"nanoad84febib47","doi-asserted-by":"publisher","first-page":"e3314","DOI":"10.1002\/btpr.3314","article-title":"Design of a bactericidal hydrogel scaffold containing genipin crosslinked HF\u201018 peptide","volume":"39","author":"Boncukcu","year":"2023","journal-title":"Biotechnol. Prog."},{"key":"nanoad84febib48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-020-03115-y","article-title":"Anti-inflammatory activity of 3-cinnamoyltribuloside and its metabolomic analysis in LPS-activated RAW 264.7 cells","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"nanoad84febib49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101925","article-title":"Synthesis, characterization and cytotoxicity of zinc oxide nanoparticles by green synthesis method","volume":"60","author":"Patr\u00f3n-Romero","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"nanoad84febib50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102743","article-title":"Mechanistic evaluations of ketoconazole lipidic nanoparticles for improved efficacy, enhanced topical penetration, cellular uptake (L929 and J774A. 1), and safety assessment: in vitro and in vivo studies","volume":"65","author":"Ramzan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"nanoad84febib51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2020.101832","article-title":"Synthesis of Ag-NPs developed by green-chemically method and evaluation of antioxidant activities and anti-inflammatory of synthesized nanoparticles against LPS-induced NO in RAW 264.7 macrophages","volume":"29","author":"Solaiman","year":"2020","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"nanoad84febib52","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4324-2023220775","article-title":"Preparation of PLGA nanoparticles loaded with the anti-infective Ctn [15\u201334] peptide for antifungal application","volume":"66","author":"Santos","year":"2023","journal-title":"Braz. Arch. Biol. Technol."},{"key":"nanoad84febib53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"first-page":"369","year":"2019","author":"Raval","key":"nanoad84febib54"},{"key":"nanoad84febib55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105830","article-title":"Enhancing the treatment of staphylococcus aureus infections: a nanosystem with including dual antimicrobial peptide","volume":"97","author":"Coksu","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"nanoad84febib56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"nanoad84febib57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/pharmaceutics15010175","article-title":"Effects of particle geometry for PLGA-based nanoparticles: preparation and in vitro\/in vivo evaluation","volume":"15","author":"Kaplan","year":"2023","journal-title":"Pharmaceutics"},{"key":"nanoad84febib58","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/nano11030749","article-title":"PLGA based nanospheres as a potent macrophage-specific drug delivery system","volume":"11","author":"Boltnarova","year":"2021","journal-title":"Nanomaterials"},{"key":"nanoad84febib59","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1007\/s11095-009-9973-4","article-title":"Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles","volume":"26","author":"Nahar","year":"2009","journal-title":"Pharm. Res."},{"key":"nanoad84febib60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpharm.2007.07.038","article-title":"PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution","volume":"349","author":"Esmaeili","year":"2008","journal-title":"Int. J. Pharm."},{"key":"nanoad84febib61","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1038\/s41467-022-30813-7","article-title":"Efficient aqueous remote loading of peptides in poly (lactic-co-glycolic acid)","volume":"13","author":"Giles","year":"2022","journal-title":"Nat. Commun."},{"key":"nanoad84febib62","doi-asserted-by":"publisher","first-page":"22518","DOI":"10.3390\/ijms151222518","article-title":"Intrinsic tryptophan fluorescence in the detection and analysis of proteins: a focus on F\u00f6rster resonance energy transfer techniques","volume":"15","author":"Ghisaidoobe","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"nanoad84febib63","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"nanoad84febib64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.08.016","article-title":"PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing","volume":"194","author":"Chereddy","year":"2014","journal-title":"J. Control. Release"},{"key":"nanoad84febib65","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2147\/IJN.S29506","article-title":"PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses","volume":"7","author":"Ma","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"nanoad84febib66","first-page":"30","article-title":"Recent biomedical applications and patents on biodegradable polymer-PLGA","volume":"1","author":"Singh","year":"2014","journal-title":"Int. J. Pharmacol. Pharm."},{"key":"nanoad84febib67","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10989-018-9753-2","article-title":"Development of vaccine prototype against zika virus disease of peptide-loaded PLGA nanoparticles and evaluation of cytotoxicity","volume":"25","author":"\u00c7alman","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"nanoad84febib68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213862","article-title":"Targeted delivery of rifaximin using P6. 2-decorated bifunctional PLGA nanoparticles for combating staphylococcus aureus infections","volume":"161","author":"Arayici","year":"2024","journal-title":"Biomater. Adv."},{"key":"nanoad84febib69","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)\/poly (lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"nanoad84febib70","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","article-title":"Phenomenology of the initial burst release of drugs from PLGA microparticles","volume":"6","author":"Yoo","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"nanoad84febib71","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.eurpolymj.2019.03.009","article-title":"Polymers for subunit vaccine delivery","volume":"114","author":"Nevagi","year":"2019","journal-title":"Eur. Polym. J."},{"key":"nanoad84febib72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems\u2014A review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"nanoad84febib73","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/02652040802211709","article-title":"Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination","volume":"26","author":"Nayak","year":"2009","journal-title":"J. Microencapsul."},{"key":"nanoad84febib74","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/ijms24032867","article-title":"Physical and functional characterization of PLGA nanoparticles containing the antimicrobial peptide SAAP-148","volume":"24","author":"Ali","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"nanoad84febib75","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/pharmaceutics14091821","article-title":"Preparation, characterization, and biological evaluation of a hydrophilic peptide loaded on PEG-PLGA nanoparticles","volume":"14","author":"Marinelli","year":"2022","journal-title":"Pharmaceutics"},{"key":"nanoad84febib76","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0168-3659(97)00065-5","article-title":"The effect of size, charge and cyclization of model peptides on their in vitro release from dl\u2013PLGA microspheres","volume":"49","author":"Okumu","year":"1997","journal-title":"J. Control. Release"},{"key":"nanoad84febib77","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/IJN.S296527","article-title":"A multiepitope peptide, rOmp22, encapsulated in chitosan-PLGA nanoparticles as a candidate vaccine against Acinetobacter baumannii infection","volume":"16","author":"Du","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"nanoad84febib78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pharmaceutics15010003","article-title":"Inhalable polymeric nanoparticles for pulmonary delivery of antimicrobial peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo","volume":"15","author":"Cresti","year":"2023","journal-title":"Pharmaceutics"},{"key":"nanoad84febib79","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/10717544.2021.1902021","article-title":"The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats","volume":"28","author":"Wang","year":"2021","journal-title":"Drug Deliv."},{"key":"nanoad84febib80","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2022.101791","article-title":"Poly (lactic-co-glycolic acid) nanoparticle-based vaccines delivery systems as a novel adjuvant for H9N2 antigen enhance immune responses","volume":"101","author":"Wusiman","year":"2022","journal-title":"Poult. Sci."},{"key":"nanoad84febib81","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1371\/journal.ppat.0030186","article-title":"Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes","volume":"3","author":"Davis","year":"2007","journal-title":"PLoS Pathog."},{"key":"nanoad84febib82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4161\/viru.20328","article-title":"The potential of nitric oxide releasing therapies as antimicrobial agents","volume":"3","author":"Schairer","year":"2012","journal-title":"Virulence"},{"key":"nanoad84febib83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: an update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends Immunol."}],"container-title":["Nanotechnology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:55:44Z","timestamp":1729259744000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad84fe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2025,1,13]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6528\/ad84fe","relation":{},"ISSN":["0957-4484","1361-6528"],"issn-type":[{"type":"print","value":"0957-4484"},{"type":"electronic","value":"1361-6528"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity","name":"article_title","label":"Article Title"},{"value":"Nanotechnology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2024 The Author(s). Published by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2024-07-29","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2024-10-09","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2024-10-18","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}